Protein Molecules as the Basis for Effective Wound Healing Drugs

The study investigates protein molecules of biological origin as the basis for effective wound healing drugs, combining scientific-biotechnological and economic-analytical approaches. It examines cellular and molecular mechanisms of wound healing, including clot formation, inflammatory response, re-epithelialization, and remodeling, highlighting the roles of neutrophils, macrophages, keratinocytes, fibroblasts, and immune cells. The research systematizes information on current protein-based wound healing products, such as collagen, keratin, fibrin, silk fibroin, hyaluronic acid, and bioactive peptides, and discusses various generations of dressing materials, protein hydrogels, and their integration with electronic wound monitoring systems. It analyzes the advantages and limitations of natural and synthetic biomaterials and regulatory requirements for biological wound healing products in Europe and Ukraine. An economic analysis of the global market for protein-based wound healing products estimates it at $2.3 billion in 2025, with a projected growth to $4.3 billion by 2033 at a CAGR of 7.05%. The market is segmented by active substance type, form, and end-user, with strategic industry prospects analyzed using SWOT and PESTLE methodologies, and marketing efficiency assessed through KPI panels and ROMI.